Danish drugmaker Novo Nordisk has appointed Ayman Hassan as the new vice president and general manager for the company's operations in Egypt. Hassan has a wealth of expertise of nearly 25 years of diverse experience in the medical field, the pharma industry, and business across the Gulf, Middle East, and South Asia. “Novo Nordisk Egypt has achieved great success over 80 years operating in the Egyptian market. During those years Novo Nordisk has established meaningful partnerships with the Egyptian government, the medical societies, as well as patient organizations." said Ayman Hassan, the company's new vice president and general manager. "We look forward to reaching new milestones in the company's history in Egypt while further augmenting our position as a genuine partner of Egypt," "It is an honour and a privilege to take on this role as we continue our commitment to helping people with diabetes and other serious chronic conditions in Egypt and around the world.” Hassan began his career with Novo Nordisk in 2000 when he joined Novo Nordisk Pharma Gulf based out of Riyadh as medico-marketing manager and eventually was promoted to director. He later assumed marketing responsibility for the Near East South Asia business area based out of Istanbul, where he helped establish and develop different sales, marketing and medical units and disciplines across countries spanning from Turkey to India. These endeavours covered a fourth of the world's population. He then moved back to the Gulf to eventually establish a fully-fledged organization in the UAE. He graduated from the Faculty of Medicine, Cairo University. In addition to his medical degree, Hassan carries a Master's Degree in Business Administration (MBA) from the U.S., a Master of Science (M.Sc.) in Global Management from the UK, a Diploma in Clinical Trials from the UK, and an Executive Management Strategy Execution Certificate from Harvard University.
